3654 results for «382»

Filter By

3654 results

Mixed VHD: how to manage?

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult this session to learn more about aortic stenosis and aortic regurgitation: how to diagnose these conditions, how to select patients for surgical or transcatheter interventions, and how to treat them.

Mixed VHD: how to manage?

Endocarditis: what can we suggest for the upcoming ESC guidelines?

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch this session to learn more about the various challenges in treating patients with endocarditis, to understand how to better diagnose valve endocarditis and to discover new transcatheter interventions after endocarditis.

Endocarditis: what can we suggest for the upcoming ESC guidelines?

The challenge of aortic regurgitation: better imaging for better clinical practice

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch this session to learn about the challenges of diagnosing aortic regurgitation and how to overcome them, to better understand the right timing for intervention based on available evidence, and to discover what tools exist to more accurately assess the severity of aortic regurgitation.

The challenge of aortic regurgitation: better imaging for better clinical practice

Contemporary imaging trends in aortic stenosis - How to diagnose

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch these presentation to know all about the latest diagnostic tools in aortic stenosis, to learn how to use 3D in aortic stenosis and to understand when 3D echo and exercise echo are useful.

Contemporary imaging trends in aortic stenosis - How to diagnose

Imaging before and after TAVI - How to treat

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult this session on imaging before and after TAVI to learn how to better select patients for TAVI, to understand how to treat paravalvular leak and to know how to deal with and prevent valve thrombosis.

Imaging before and after TAVI - How to treat

Where are we going? The symptomatic patient with moderate aortic stenosis

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Watch these presentations on symptomatic patient with moderate aortic stenosis to learn to evaluate outcomes after TAVI, to better assess aortic stenosis and LV function, and to expand your knowledge in infiltrative diseases.

Where are we going? The symptomatic patient with moderate aortic stenosis

Diagnosis of disease type and of disease severity

10 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult this session to learn how to better assess mitral regurgitation and how to better diagnose mitral stenosis through imaging.

Diagnosis of disease type and of disease severity

Multiple VHD: a diagnostic and clinical challenge

11 Mar 2023 – From PCR Imaging Valves Madrid 2023

Consult these presentations on multiple VHD to learn how to deal with combined valvular lesions, how to assess their severity and how to treat them.

Multiple VHD: a diagnostic and clinical challenge

POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?

02 Sep 2024

Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.

Luis Ortega-Paz

Author

Luis Ortega-Paz
POPular PAUSE TAVI

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials

14 Nov 2021

Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.

Vijay Kunadian

Author

Vijay Kunadian
Best of #AHA21 Scientific sessions

Evidence base: current data on TAVI durability and long-term outcomes

18 Jun 2026

This article reviews the current evidence on TAVI durability, focusing on long-term outcomes, device-specific considerations, and the implications for lifetime management strategies.

Tanja Rudolph

Author

Tanja Rudolph
Georges El Hachem

Author

Georges El Hachem
Evidence base: current data on durability

ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines

29 Aug 2021

There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag

Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)

30 Oct 2024

Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.

Ali Nazmi Calik

Author

Ali Nazmi Calik
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
Didn’t find what you were looking for?